Shopping Cart
- Remove All
- Your shopping cart is currently empty
HIV-1 inhibitor-47 is a compound that effectively inhibits HIV-1 by preventing the vif-dependent degradation of human APOBEC3G. It has a notable inhibition effect, with an IC50 value of 14.33 μM. Additionally, HIV-1 inhibitor-47 is involved in the synthesis of derivatives of 1-(2-pyrimidinyl)piperazine, which have the potential to exhibit antianxiety, antidepressant, and antipsychotic effects [1] [2] [3].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | HIV-1 inhibitor-47 is a compound that effectively inhibits HIV-1 by preventing the vif-dependent degradation of human APOBEC3G. It has a notable inhibition effect, with an IC50 value of 14.33 μM. Additionally, HIV-1 inhibitor-47 is involved in the synthesis of derivatives of 1-(2-pyrimidinyl)piperazine, which have the potential to exhibit antianxiety, antidepressant, and antipsychotic effects [1] [2] [3]. |
In vitro | APOBEC3G (A3G), a host cytidine deaminase, inhibits HIV-1 replication through its antiviral activity. Nonetheless, HIV-1 circumvents this defense by exploiting the cellular ubiquitin/proteasome degradation pathway [1]. HIV-1 inhibitor-47 targets the APOBEC3G-apolipoprotein B mRNA editing enzyme catalytic subunit 3G (human), disrupting the HIV-1 Vif-APOBEC3G interaction [2]. |
Molecular Weight | 242.28 |
Formula | C12H14N6 |
Cas No. | 137448-39-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.